MedTrace Logo

Long Term Outcome in ICU Treated COVID-19: New Chronic Diseases

NCT05075096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60000

Last updated 2022-05-24

No results posted yet for this study

Summary

Additional chronic diseases one year after intensive care unit (ICU) admission with Coronavirus disease 2019 (COVID-19) will be assessed in comparison to two control cohorts.

The ICU population comprises all Swedish ICU patients with COVID-19 with at least one year of follow up. The hospital admitted cohort comprises four hospital admitted patients with COVID-19 per ICU patient, matched on age, legal gender and region. The general population controls are matched to the ICU patients in a one to four fashion on age, legal gender and region.

ICU patients are identified in the Swedish intensive care registry. The hospital admitted patients are identified in the national patient registry and the population controls are identified in the population registry. Data on comorbidity, medications and death are provided from the National board of health and welfare.

Conditions

  • Covid19

Interventions

OTHER

No intervention.

No intervention observational study.

Sponsors & Collaborators

  • Dalarna County Council, Sweden

    collaborator OTHER

  • Uppsala University

    lead OTHER

Principal Investigators

  • Miklos Lipcsey, Professor · 202100-2932

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-15
Primary Completion
2021-11-15
Completion
2021-11-15

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05075096 on ClinicalTrials.gov